Advanced Research Center, Inc., Anaheim
Neuro-Pain Research Center, Fresno
Altman Clinical and Translational Research Institute, University of California San Diego, La Jolla
fi 4 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT04743141

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Advanced Research Center /ID# 270257, Anaheim
Neuro Pain Research Center /ID# 271048, Fresno
Accellacare - Long Beach /ID# 270398, Long Beach
fi 3 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06810505

Responding With Evidence and Access for Childhood Headaches

University of California San Francisco, San Francisco

Namoota walitti qabaa jira

Umuriin 10 hanga 17 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT05889624

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Keck School of Medicine of USC, Los Angeles
Clinical Research Institute, Los Angeles
Desert Physicians Medical Group, Palm Springs
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Advanced Research Center /ID# 227962, Anaheim
Neuro Pain Research Center /ID# 227966, Fresno
Imax Clinical Trials /ID# 281436, La Palma
fi 7 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT05125302

Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients

Sunwise Clinical Research, Llc, Walnut Creek

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07646613

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Axiom Research, LLC, Colton
ProScience Research Group, Culver City
Leading Edge Research LA, LLC, Encino
fi 15 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07645924

Emgality for Migraine in Breastmilk

University of California, San Francisco, San Francisco

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 hanga 45 · Dubartoota · Haaromfame 11-Hag-2026 · NCT06085144

Treatment of Meniere's Disease With Migraine Medications

University of California, Irvine Medical Center ENT Clinic (Pavilion 2), Orange

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 25 hanga 85 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT05582837

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

The Neurology Center of Southern California - Carlsbad Office, La Jolla
Clinical Research Institute, LCC, Los Angeles

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT06602479

Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

Peter H Hwang, Stanford

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 27-Elb-2026 · NCT04930887

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

Neurology and Pain Specialty Center /ID# 278508, Aliso Viejo

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Gur-2026 · NCT07310290

Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics

Stanford University School of Medicine, Stanford

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ado-2025 · NCT03231241

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

Upsher-Smith Clinical Trial Site #15, La Jolla

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 6 hanga 11 · Saalaa hunda · Haaromfame 27-Ama-2025 · NCT04748601

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.